Shows
EASL Video PodcastsEASL Studio Podcast: Collaborating across disciplines to find the best solution for people living with PBCThis EASL Studio episode brings key insights from the 2025 EASL–AASLD Consensus Conference on Primary Biliary Cholangitis (PBC).
Experts explore the use of surrogate endpoints, the challenges in current trial design and regulation, the value of real-world evidence, and how quality-of-life assessment can support future pathways.
Moderator: David Jones
Speakers: Marco Carbone, Bettina Hansen, and Ana Lleo
All EASL Studio Podcasts are available on EASL Campus.
Click here to see all EASL Video Podcasts on Apple Podcasts.
2025-12-1833 min
EASL PodcastsEASL Studio Podcast: Collaborating across disciplines to find the best solution for people living with PBCThis EASL Studio episode brings key insights from the 2025 EASL–AASLD Consensus Conference on Primary Biliary Cholangitis (PBC).Experts explore the use of surrogate endpoints, the challenges in current trial design and regulation, the value of real-world evidence, and how quality-of-life assessment can support future pathways.Moderator: David JonesSpeakers: Marco Carbone, Bettina Hansen, and Ana LleoAll EASL Studio Podcasts are available on EASL Campus.Click here to see all EASL Video Podcasts on Apple Podcasts.
2025-12-1833 min
EASL Video PodcastsEASL Studio Podcast: What Can Be Done to Safeguard Young Adults from SLD?How can we protect young adults from steatotic liver disease (SLD)? This episode explores the burden of MASLD, MetALD, and ALD in Europe, the synergistic effects of alcohol and metabolic risk factors, and why the younger population is especially vulnerable. Experts also examine the disparities in risk factors and the role of clinics and policymakers in prevention.
Moderator: Shira Zelber Sagi
Speakers: Carina Ferreira-Borges (WHO representative) and Zobair Younossi
This EASL Studio is supported by Opella. EASL has received no input from Opella with regards to the content of this programme.
Al...
2025-12-1141 min
EASL PodcastsEASL Studio Podcast: What Can Be Done to Safeguard Young Adults from SLD?How can we protect young adults from steatotic liver disease (SLD)? This episode explores the burden of MASLD, MetALD, and ALD in Europe, the synergistic effects of alcohol and metabolic risk factors, and why the younger population is especially vulnerable. Experts also examine the disparities in risk factors and the role of clinics and policymakers in prevention.Moderator: Shira Zelber SagiSpeakers: Carina Ferreira-Borges (WHO representative) and Zobair YounossiThis EASL Studio is supported by Opella. EASL has received no input from Opella with regards to the content of...
2025-12-1140 minEASL Video PodcastsEASL Studio Podcast: Decoding AASLD The Liver Meeting: Trends Shaping HepatologyWhat were the key takeaways from this year’s AASLD The Liver Meeting? In this episode, experts unpack the most impactful studies, clinical insights, and emerging trends shaping the future of hepatology. From liver cancer breakthroughs to MASLD, ALD, and beyond.
Moderator: Debbie Shawcross
Speakers: Saul Karpen, Allison Kwong, Mazen Noureddin
All EASL Studio Podcasts are available on EASL Campus.
Click here to see all EASL Video Podcasts on Apple Podcasts.
2025-12-0436 minEASL Video PodcastsEASL Studio Podcast: Rifaximin for Hepatic Encephalopathy: Balancing Benefits and Risks in the Era of Antimicrobial ResistanceFor World Antimicrobial Awareness Week 2025 (“Act Now: Protect Our Present, Secure Our Future”), this EASL Studio explores the balance between rifaximin’s benefits in hepatic encephalopathy and the global challenge of antimicrobial resistance.
Moderator: Debbie Shawcross
Speakers: Rajiv Jalan, Vishal Patel, Jonel Trebicka
All EASL Studio Podcasts are available on EASL Campus.
Click here to see all EASL Video Podcasts on Apple Podcasts.
This EASL Studio is supported by Alfasigma and Norgine. EASL has received no input from Alfasigma or Norgine with regards to the content of this program
2025-11-2737 minEASL PodcastsEASL Studio Podcast: Rifaximin for Hepatic Encephalopathy: Balancacing Benefits and Risks in the Era of Antimicrobial ResistanceFor World Antimicrobial Awareness Week 2025 (“Act Now: Protect Our Present, Secure Our Future”), this EASL Studio explores the balance between rifaximin’s benefits in hepatic encephalopathy and the global challenge of antimicrobial resistance.Moderator: Debbie ShawcrossSpeakers: Rajiv Jalan, Vishal Patel, Jonel TrebickaAll EASL Studio Podcasts are available on EASL Campus.Click here to see all EASL Video Podcasts on Apple Podcasts.This EASL Studio is supported by Alfasigma and Norgine. EASL has received no input from Alfasigma or Norgine with regard...
2025-11-2736 minEASL Video PodcastsEASL Studio Podcast: Behind the Decision: How Can You Maximize Your Chances of Publication in JHEP Reports?Ever wondered what happens to your manuscript after submission? In this episode, the JHEP Reports editorial team takes you behind the scenes: from first triage to reviewer selection, smart moves vs. red flags, and how final decisions are made. The discussion also explores the potential, limitations, and ethical pitfalls.
Moderator: Mattias Mandorfer
Speakers: Tobias Böttler, Virginia Hernández-Gea, and Josep Llovet
All EASL Studio Podcasts are available on EASL Campus.
Click here to see all EASL Video Podcasts on Apple Podcasts.
2025-11-1331 minEASL Video PodcastsEASL Studio Podcast: Are we finally entering an era of effective treatment for PSC?After years of limited progress, recent trials hint at a changing landscape for primary sclerosing cholangitis (PSC). In this episode, experts review emerging data and explore whether we’re approaching a new era of effective treatment. How should clinicians assess these therapies, and could they shift the current management of PSC?
Moderator: Debbie Shawcross
Speakers: Cynthia Levy, Stephen Rossi, Michael Trauner
All EASL Studio Podcasts are available on EASL Campus.
Click here to see all EASL Video Podcasts on Apple Podcasts.
2025-11-0644 minEASL Video PodcastsEASL Studio Podcast: Does it really matter whether we call it ACLF or acute decompensation?This episode questions whether assigning the label “ACLF” to a deteriorating patient truly alters clinical decisions, or if focusing on the specifics of organ failure and reversibility is more useful. Experts debate the real-world utility of prognostic scores, the clarity (or confusion) created by multiple definitions, and whether the ACLF concept drives urgency, facilitates transplant access, or improves outcomes. A thought-provoking look at where terminology meets bedside care.
Moderator: Tom Marjot
Speakers: Paolo Angeli and Julia Wendon
This EASL Studio is supported by GENFIT. EASL has received no input from GENFIT with regards to the...
2025-10-0940 min
EASL PodcastsEASL Studio Podcast: Does it really matter whether we call it ACLF or acute decompensation?This episode questions whether assigning the label “ACLF” to a deteriorating patient truly alters clinical decisions, or if focusing on the specifics of organ failure and reversibility is more useful. Experts debate the real-world utility of prognostic scores, the clarity (or confusion) created by multiple definitions, and whether the ACLF concept drives urgency, facilitates transplant access, or improves outcomes. A thought-provoking look at where terminology meets bedside care.Moderator: Tom Marjot Speakers: Paolo Angeli and Julia WendonThis EASL Studio is supported by GENFIT. EASL has received no input from...
2025-10-0931 min
Gastroenterology & EndoscopyENDURO Trial Results, EASL Hepatitis B Guidelines 2025, AI in Endoscopy & IBS Biomarkers | Latest GI UpdatesIn this episode, we cover five crucial updates shaping gastroenterology and endoscopy practice in 2025. From the practice-changing ENDURO trial comparing endoscopic to surgical approaches for malignant gastric outlet obstruction, to the latest EASL hepatitis B management guidelines, AI applications in endoscopy, sedation innovations, and biomarker-driven approaches to IBS.Resources & LinksENDURO Trial & EUS-Guided GastroenterostomyENDURO Study Protocol - Trials JournalENDURO Trial Results - The Lancet Gastroenterology & HepatologyEUS-GE Overview - Gastroenterology & Endoscopy NewsProspective Study - Gastrointestinal EndoscopyEASL 2025 Hepatitis B GuidelinesEASL HBV Guidelines 2025 - Journal of HepatologyEASL Guidelines Summary...
2025-10-0613 min
EASL Video PodcastsEASL Studio Podcast The Clinical Blind Spot: Are We Neglecting Alcohol?This EASL Studio explores the discrepancy between the huge burden of patients hospitalised with, and dying from, alcohol-related liver disease (ALD) or MetALD, versus the same disease’s near non-existence from population data. The panel will discuss whether current classification systems (heavily favoring metabolic causes) misrepresent the true burden of ALD and MetALD, and what clinicians can do to better map the role of alcohol in liver patients.
Moderator: Maja Thiele
Speakers: Brian Lee, Mzamo Mbelle, Elisa Pose
All EASL Studio Podcasts are available on EASL Campus.
Click here to see all EAS...
2025-10-0235 minEASL Video PodcastsEASL Studio Podcast: Hepatitis C, Re-infection or Failure of Treatment in People Engaging in High Risk Practices – Do These Labels Matter in 2025?What do we call it when someone with high-risk practices becomes viraemic again after treatment? In this episode, experts discuss the challenges of managing Hepatitis C in people who inject drugs (PWID) and other high-risk groups. Topics include SVR confirmation rates, DAA prescribing practices, acute vs. chronic infection, and real-world reinfection data. Are traditional labels still meaningful or do we need new frameworks for 2025?
Moderator: Ahmed Elsharkawy
Speakers: Ashley Brown, Tatyana Kushner and Sabela Lens
This EASL Studio is supported by AbbVie. EASL has received no input from AbbVie with regards to the co...
2025-09-2536 min
EASL Video PodcastsEASL Studio Podcast: What Matters Most? The questions every hepatologist should ask their patientsIn hepatology, effective care goes beyond diagnostics and treatment. This episode explores the crucial questions hepatologists should ask to truly understand their patients’ needs, values, and priorities. By focusing on communication and patient-centred care, our experts highlight how listening carefully can improve adherence, enhance quality of life, and ultimately lead to better outcomes.
Moderator: Pierre-Emmanuel Rautou
Speakers: Agnès Dumas, Maria Hjorth, José Willemse, Zobair Younossi
All EASL Studio Podcasts are available on EASL Campus.
Click here to see all EASL Video Podcasts on Apple Podcasts.
2025-09-1833 min
EASL Video PodcastsEASL DeepDive: Diagnosis, non-invasive screening and risk stratification of MASLD casesThis first session in a two-part EASL DeepDive series on the 2024 EASL-EASD-EASO MASLD Clinical Practice Guidelines will provide a detailed examination of the recommendations concerning diagnosis, non-invasive assessment, and risk stratification, with a view to supporting evidence-based clinical practice.
Learning objectives
Have a good understanding of the concept/definition of MASLD within the framework of the new SLD nomenclature, including its contribution to disease progression in other diseases
Get familiar with the role of non-invasive tests for risk stratification in MASLD, their pro- and cons, and how and in whom to use them for screening/case...
2025-06-271h 06EASL Video PodcastsEASL Studio Podcast: EASL CPGs on Vascular Liver Diseases: What’s New?This episode addresses key challenges in vascular complications of liver disease, including the management of portal vein thrombosis (PVT) in patients with and without cirrhosis. Experts will explore controversies surrounding long-term anticoagulation therapy and discuss insights from the CIRROXABAN paper. Additionally, the episode will shed light on the management of splanchnic artery aneurysms, offering valuable guidance for clinical practice.
Moderator: Pierre-Emmanuel Rautou
Faculty: Sarwa Darwish Murad, Juan-Carlos Garcia-Pagan, Valérie Vilgrain
Related episodes
S4E11 – YI Choice: Gene therapy for liver disease — RNA interference and beyond
S4E6 – Regenerating the liver graft with a ma...
2025-06-1933 min
EASL Video PodcastsEASL DeepDive: MASLD Cirrhosis: Addressing unmet needs and defining valuable endpointsIn this new edition of the EASL DeepDive, expert faculty guide participants through a focused and forward-looking discussion on key aspects of advanced MASLD, setting the stage for a deeper understanding of evolving clinical challenges and opportunities.
This EASL DeepDive webinar is supported by Boehringer Ingelheim. Boehringer Ingelheim has had no input into the content of this EASL DeepDive.
Learning objectives
Understand the Pathophysiology: Describe the key pathophysiological mechanisms of MASLD and its progression to advanced liver disease and portal hypertension.
Identify Unmet Clinical Needs: Recognise the current gaps in diagnosis, management, and treatment...
2025-06-131h 10
EASL PodcastsEASL DeepDive: MASLD Cirrhosis: Addressing unmet needs and defining valuable endpointsIn this new edition of the EASL DeepDive, expert faculty guide participants through a focused and forward-looking discussion on key aspects of advanced MASLD, setting the stage for a deeper understanding of evolving clinical challenges and opportunities.This EASL DeepDive webinar is supported by Boehringer Ingelheim. Boehringer Ingelheim has had no input into the content of this EASL DeepDive.Learning objectivesUnderstand the Pathophysiology: Describe the key pathophysiological mechanisms of MASLD and its progression to advanced liver disease and portal hypertension.Identify Unmet Clinical Needs: Recognise the current gaps in diagnosis, management...
2025-06-131h 10EASL Video PodcastsEASL Studio Podcast: Steatotic Liver Disease Unpacked: Targeting Dynamic RisksThis EASL Studio episode explores state-of-the-art practices in diagnosing steatotic liver disease and stratifying patients effectively for targeted treatment in 2025. Focusing on integrating cardiometabolic risk profiling and dynamic alcohol consumption assessment, the discussion will discuss contemporary methods, frequency, and practical implementation in clinical settings to enhance precision medicine approaches.
Moderator: Aleksander Krag
Faculty: Meena Bansal, Mattias Ekstedt, Arun Sanyal
All EASL Studio Podcasts are available on EASL Campus.
Click here to see all EASL Video Podcasts on Apple Podcasts.
2025-06-1236 min
EASL Video PodcastsEASL Studio Podcast: Artificial Intelligence: Is This the Beginning of the End of the Medical Profession as We Know It?Listen to this EASL Studio episode to explore how artificial intelligence (AI) is transforming healthcare. Discuss its potential to revolutionise medical practice, its limitations, and whether it poses a threat or an opportunity for the future of the medical profession.
Moderator: Ahmed Elsharkawy
Faculty: Jakob Kather, Sabela Lens, Ashley Spann
Related episodes:
EASL Studio at EASL Congress 2024 – Exploring new frontiers: The AI liver taskforce initiative
S4E5 – AI for dummies
S2E13 – Digital Pathology
All EASL Studio Podcasts are available on EASL Campus.
Click here to see all EASL Video Podcasts o...
2025-06-0538 min
EASL PodcastsEASL Studio Podcast: Artificial Intelligence: Is This the Beginning of the End of the Medical Profession as We Know It?Listen to this EASL Studio episode to explore how artificial intelligence (AI) is transforming healthcare. Discuss its potential to revolutionise medical practice, its limitations, and whether it poses a threat or an opportunity for the future of the medical profession.Moderator: Ahmed Elsharkawy Faculty: Jakob Kather, Sabela Lens, Ashley Spann Related episodes:EASL Studio at EASL Congress 2024 – Exploring new frontiers: The AI liver taskforce initiativeS4E5 – AI for dummiesS2E13 – Digital PathologyAll EASL Studio Podcasts are available on EASL Campus.Click here to see a...
2025-06-0536 min
EASL Video PodcastsEASL Studio Podcast: Rethinking Hepatitis B: Discussions with Patients – Adapting to Expanding Treatment GuidelinesWith the release of the new HBV guidelines, treatment eligibility broadens. This EASL Studio explores how to communicate these changes, support shared decision-making, ensure adherence, and engage patients in ongoing care and clinical trials.
Moderator: Ahmed Elsharkawy
Faculty: Markus Cornberg, Sital Shah, Thomas Tu, Su Wang
This EASL Studio is supported by Aligos Therapeutics and Gilead Sciences Europe Ltd . EASL has received no input from Aligos Therapeutics or Gilead Sciences Europe Ltd with regards to the content of this programme.
All EASL Studio Podcasts are available on EASL Campus.
Clic...
2025-05-2937 min
EASL PodcastsEASL Studio Podcast: Rethinking Hepatitis B: Discussions with Patients – Adapting to Expanding Treatment GuidelinesWith the release of the new HBV guidelines, treatment eligibility broadens. This EASL Studio explores how to communicate these changes, support shared decision-making, ensure adherence, and engage patients in ongoing care and clinical trials.Moderator: Ahmed Elsharkawy Faculty: Markus Cornberg, Sital Shah, Thomas Tu, Su WangThis EASL Studio is supported by Aligos Therapeutics, GSK and Gilead Sciences Europe Ltd . EASL has received no input from Aligos Therapeutics, GSK or Gilead Sciences Europe Ltd with regards to the content of this programme.All EASL Studio Podcasts are a...
2025-05-2936 min
EASL Video PodcastsEASL Studio Podcast: Interprofessional Session: Implementing the New EASL MASLD Guidelines into Clinical PracticeListen to this EASL Studio episode for insights on the new MASLD guidelines and their practical application. Hear from experts on navigating the nomenclature change, implementing guidelines in clinical workflows, and fostering behavioral change to improve patient outcomes across the care team.
Moderator: Sven Francque
Faculty: Marta Cervera, Elena George, Shelley Keating
This programme is part of the EASL Guidelines Implementation Programme on MASLD supported by Boehringer Ingelheim and Madrigal Pharmaceuticals. Boehringer Ingelheim or Madrigal Pharmaceuticals have had no input in the selection and creation of this programme.
Related episode
S5E...
2025-05-2228 min
EASL PodcastsEASL Studio Podcast: Interprofessional Session: Implementing the New EASL MASLD Guidelines into Clinical PracticeListen to this EASL Studio episode for insights on the new MASLD guidelines and their practical application. Hear from experts on navigating the nomenclature change, implementing guidelines in clinical workflows, and fostering behavioral change to improve patient outcomes across the care team.Moderator: Sven Francque Faculty: Marta Cervera, Elena George, Shelley KeatingThis programme is part of the EASL Guidelines Implementation Programme on MASLD supported by Boehringer Ingelheim and Madrigal Pharmaceuticals. Boehringer Ingelheim or Madrigal Pharmaceuticals have had no input in the selection and creation of this programme.
2025-05-2227 min
EASL Video PodcastsEASL Studio Podcast: Screening strategies for liver fibrosisMost liver diseases are diagnosed when it’s already too late. This episode explores the pros and cons of early screening, the gaps in current strategies, and how projects like LIVERAiM are aiming to change the game.
Moderator: Ahmed Elsharkawy
Faculty: Pere Ginès, Ian Rowe, Maja Thiele
All EASL Studio Podcasts are available on EASL Campus.
Click here to see all EASL Video Podcasts on Apple Podcasts.
2025-05-2031 min
EASL Video PodcastsEASL/CIRSE Studio Podcast: Interventional radiology in hepatology: Building bridges to optimise careWhat happens when hepatologists and interventional radiologists join forces? This episode discusses the power of collaboration – shared guidelines, joint training, and multidisciplinary care – to improve outcomes in complex liver disease.
Moderator: Sven Francque
Faculty: Irene Bargellini, Virginia Hernández-Gea, Max Seidensticker
All EASL Studio Podcasts are available on EASL Campus.
Click here to see all EASL Video Podcasts on Apple Podcasts.
2025-05-2030 min
EASL Video PodcastsEASL Studio Podcast: Landmark studies at EASL Congress 2025Listen to this episode for a curated overview of landmark studies and breakthrough data presented at EASL Congress 2025, with expert insights on their clinical relevance and impact on the future of hepatology.
Moderator: Thomas Berg
Faculty: Hannes Hagström, Verena Keitel, Raj Mookerjee
All EASL Studio Podcasts are available on EASL Campus.
Click here to see all EASL Video Podcasts on Apple Podcasts.
2025-05-2036 min
EASL Video PodcastsEASL Studio Podcast: Beyond the myths: Alcohol harm and policy actionThis EASL Studio episode cuts through the noise to explore alcohol’s true impact on health and society, spotlighting patient stories, public misconceptions, and bold policy solutions from across Europe.
Moderator: David Barret (Internal Communications and Multimedia Manager, WHO Regional Office for Europe)
Faculty: Carina Ferreira-Borges (Regional Advisor for Alcohol, Illicit drugs and Prison health, WHO Regional Office for Europe), Aleksander Krag (EASL Secretary General), Hazel Martin (BBC Journalist and Liver Patient), Margarida Santos (General Practitioner Portugal), Riina Sikkut (Member of Estonian Parliament, former Minister of Health of Estonia)
All EASL Studio Podcasts are...
2025-05-2047 min
EASL PodcastsEASL Studio Podcast: Beyond the myths: Alcohol harm and policy actionThis EASL Studio episode cuts through the noise to explore alcohol’s true impact on health and society, spotlighting patient stories, public misconceptions, and bold policy solutions from across Europe.Moderator: David Barret (Internal Communications and Multimedia Manager, WHO Regional Office for Europe)Faculty: Carina Ferreira-Borges (Regional Advisor for Alcohol, Illicit drugs and Prison health, WHO Regional Office for Europe), Aleksander Krag (EASL Secretary General), Hazel Martin (BBC Journalist and Liver Patient), Margarida Santos (General Practitioner Portugal), Riina Sikkut (Member of Estonian Parliament, former Minister of Health of Estonia)Al...
2025-05-2047 min
EASL PodcastsEASL Studio Podcast: Landmark studies at EASL Congress 2025Listen to this episode for a curated overview of landmark studies and breakthrough data presented at EASL Congress 2025, with expert insights on their clinical relevance and impact on the future of hepatology.Moderator: Thomas Berg Faculty: Hannes Hagström, Verena Keitel, Raj MookerjeeAll EASL Studio Podcasts are available on EASL Campus.Click here to see all EASL Video Podcasts on Apple Podcasts.
2025-05-2036 min
EASL Video PodcastsEASL DeepDive: Key for TIPS Success: Identifying Suitable Candidates and Risk ControlIn this fifth edition of the EASL DeepDive, join Christophe Bureau, Virginia Hernandez-Gea, Marika Rudler, and Manhal Izzy to gain expert insight into the selection, management, and outcomes of patients undergoing Transjugular Intrahepatic Portosystemic Shunt (TIPS) procedures.
This EASL DeepDive webinar is supported by W. L. Gore & Associates. W. L. Gore & Associates has had no input into the content of this EASL DeepDive.
Learning objectives
Understand the criteria for selecting appropriate patients for Transjugular Intrahepatic Portosystemic Shunt (TIPS) procedures
Learn to differentiate between high-risk and low-risk patients based on clinical indicators and patient history
Explore the...
2025-05-151h 32
EASL PodcastsEASL DeepDive: Key for TIPS Success: Identifying Suitable Candidates and Risk ControlIn this fifth edition of the EASL DeepDive, join Christophe Bureau, Virginia Hernandez-Gea, Marika Rudler, and Manhal Izzy to gain expert insight into the selection, management, and outcomes of patients undergoing Transjugular Intrahepatic Portosystemic Shunt (TIPS) procedures.This EASL DeepDive webinar is supported by W. L. Gore & Associates. W. L. Gore & Associates has had no input into the content of this EASL DeepDive.Learning objectivesUnderstand the criteria for selecting appropriate patients for Transjugular Intrahepatic Portosystemic Shunt (TIPS) proceduresLearn to differentiate between high-risk and low-risk patients based on clinical indicators and patient...
2025-05-151h 32
EASL Video PodcastsEASL Studio Podcast: Endoscopic Management of Variceal Bleeding: Outdated or Evolving Beyond Tradition?This EASL Studio episode discusses cutting-edge approaches for managing bleeding varices. Explore the evolution of endoscopic therapies, the role of interventional radiology, and decision-making for high-risk gastric varices. Gain insights into EUS-guided portal pressure assessment and its impact on tailoring treatment strategies.
Moderator: Debbie Shawcross
Faculty: Wim Laleman, David Patch
Related episode
S6E14: Endohepatology: The endoscopic liver gold rush
All EASL Studio Podcasts are available on EASL Campus.
Click here to see all EASL Video Podcasts on Apple Podcasts.
2025-04-1046 minEASL Video PodcastsEASL Studio Podcast: JHEP Live: JHEP at 40: What to Expect Next?This episode celebrates 40 years of the Journal of Hepatology, EASL’s flagship journal.
Tune in to discover how far we’ve come—and what’s next for the journal.
Moderator: Thomas Berg
Faculty: Paolo Angeli, Annalisa Berzigotti, Rajiv Jalan, Vlad Ratziu, Frank Tacke and Jessica Zucman-Rossi
All EASL Studio Podcasts are available on EASL Campus.
Click here to see all EASL Video Podcasts on Apple Podcasts.
2025-04-101h 02
EASL Video PodcastsEASL Studio Podcast: Rare Liver Malignancies: Small Numbers, Big QuestionsRare liver tumors like combined HCC/CCA, fibrolamellar HCC, and haemangioendothelioma pose significant diagnostic and therapeutic challenges. In this episode, we explore the latest insights, controversies, and clinical approaches outlined in the new EASL position paper. Join us to uncover how these advancements can address key hurdles in managing these rare malignancies.
Read the position paper: Rare primary liver cancers: An EASL position paper
Moderator: Thomas Berg
Faculty: Ruben de Kleine and Henning Wege
Related episodes
S6E4: World Cholangiocarcinoma Day: Highlighting guidelines and exploring the horizon beyond
S5E13: Basi...
2025-04-1045 min
EASL Video PodcastsEASL Studio Podcast: From Evidence to Action: Reducing Alcohol-Related HarmThis episode of EASL Studio explores insights from the European Alcohol Health Alliance Symposium, hosted by the WHO Regional Office for Europe in collaboration with EASL. Topics include managing alcohol marketing strategies, addressing gaps in cancer-related labelling, and understanding the influence of social norms on adolescent alcohol consumption. Learn from successful alcohol policy implementations and discover how the WHO Playbook can empower advocates to protect children and reshape public health strategies for alcohol-related harm.
Moderator: Shira Zelber-Sagi
Faculty: Frank Murray, Catherine Paradis (WHO Europe) and Debbie Shawcross
Related episodes
S7E5 Why doe...
2025-04-1032 min
EASL Video PodcastsEASL Studio Podcast: Understanding Sex Disparities in MASLDMetabolic dysfunction-associated steatotic liver disease (MASLD) affects men and women differently, yet sex-based differences remain poorly explored. In the week celebrating International Women’s Day, this EASL Studio episode debates the molecular, hormonal, and genetic mechanisms driving these disparities.
Moderator: Saskia van Mil
Faculty: Sara Della Torre and Münevver Demir
Related episode
S4E9 YI Choice: Gender equality in academics — reducing the gap
All EASL Studio Podcasts are available on EASL Campus.
Click here to see all EASL Video Podcasts on Apple Podcasts.
2025-04-1041 min
EASL Video PodcastsEASL Studio Podcast: Lessons from Your PET: Understanding and Evaluating Treatment for Wilson’s DiseaseTune into this EASL Studio episode to learn about the role of PET imaging in Wilson’s disease. Discover how PET advances understanding, supports treatment decisions, and enhances patient care in managing this rare liver disorder.
Moderator: Debbie Shawcross
Faculty: Aftab Ala, Zoe Mariño and Thomas Sandahl
This EASL Studio is supported by Orphalan and Univar Solutions.
EASL has received no input from Orphalan or Univar Solutions with regards to the content of this programme.
Related episodes
S4E15: Diagnostic and therapeutic challenges in Wilson’s disease
S4E7: Genet...
2025-04-1039 min
EASL Video PodcastsEASL Studio Podcast: Liver Cancer Care in 2025: Progress, Hope, and What Lies AheadJoin this EASL Studio episode for a clinical perspective on advancing HCC care. Explore the realities of adjuvant therapies, emerging molecular targets, and strategies for curative conversion. Gain insights into practical innovations shaping the future and translating research into improved patient outcomes.
Moderator: Thomas Berg
Faculty: Tim Greten and Anna Saborowski
This EASL Studio is supported by Bayer.
EASL has received no input from Bayer with regards to the content of this programme.
Related episodes
EASL Studio S5E13: Basics in decision-making for liver cancer treatment
EASL Studio from EASL C...
2025-04-1045 min
EASL Video PodcastsEASL Studio Podcast: YI choice: From Idea to Abstract to Publication: Navigating Your Research journeyWatch this EASL Studio to start navigating your research journey with essential tips on generating ideas, refining hypotheses, and crafting standout abstracts for EASL Congress. Discover how to choose the right journal, prepare a submission-ready manuscript, and boost your career visibility in hepatology.
Moderator: Thomas Marjot
Faculty: Marta Afonso, Emma Andersson and Paolo Angeli
Related episodes
S4E20 – COST Actions: Opportunities for pan-European collaborations in liver diseases
S4E14 – EASL-EF CLIF and EU Grants: Exploring novel mechanism and treatment of chronic liver failure
S4E2 YI Choice – How to build consortia and registries
All EAS...
2025-04-1032 min
EASL Video PodcastsEASL Studio Podcast: JHEP Live – EASL CPGs on Hepatocellular Carcinoma: What’s New and How Will Practice Change?Discover the latest updates from the updated EASL Clinical Practice Guidelines on Hepatocellular Carcinoma (HCC). This episode explores key advancements, their impact on clinical practice, and how they will shape the future of HCC diagnosis, treatment, and management. Join our faculty as they break down the changes and provide practical insights for healthcare professionals.
Moderator: Thomas Berg
Faculty: Peter Galle, Josep Llovet and Lorenza Rimassa
Related episodes
EASL Studio S6E4: World Cholangiocarcinoma Day: Highlighting Guidelines and Exploring the Horizon Beyond
EASL Studio S6E9: Therapy Hierarchy in HCC: A New Kid on th...
2025-04-1049 min
EASL Video PodcastsEASL Studio Podcast: 2025 Update on Steatotic Liver Disease: Rethinking Standard of CareJoin us for the season premiere of EASL Studio Season 8 as we unpack key insights from the Steatotic Liver Disease (SLD) Summit. Explore the evolving consensus on patient trajectories, advancements in ALD and MetALD treatment pathways, and the latest endpoint discussions. The episode also highlights a holistic approach to diagnosing and managing comorbidities and revisits the standard of care in light of breakthroughs in MASH treatments.
Moderator: Aleksander Krag
Faculty: Cyrielle Caussy, Sven Francque and Brian Lee
This EASL Studio is supported by Madrigal. EASL has received no input from Madrigal with regards to...
2025-04-1035 min
EASL Video PodcastsEASL DeepDive: Understanding and managing PBC symptomsIn this EASL DeepDive held on 03 July 2024, Palak Trivedi, Emma Culver, Andreas Kremer and Jessica Dyson explain the risk assessment in people with PBC as well as the mechanistic and treatment of fatigue and pruritus.
Learning objectives
Discover the latest mechanistic insights relating to the occurrence of PBC symptoms
Learn more about the holistic management of PBC symptoms, with a particular emphasis on fatigue and pruritus
Learn more about the current treatment options, their efficacy and limitations
Get a detailed understanding of the drugs in the pipeline for the near future
This EASL DeepDive webinar...
2025-04-041h 15
EASL Video PodcastsEASL DeepDive: Glucagon in MASH: A next step in “metabolic” drugs tackling liver disease?In this EASL DeepDive held on 30 October 2024, Henning Grønbæk, Cyrielle Caussy, Mazen Noureddin and Frank Tacke provide an understanding of the role of glucagon and glucagon-receptors in physiology and in MASH patients. Additionally, they review key clinical trials and evaluate the integration of GLP-1 receptor agonists into current EASL-EASD-EASO clinical guidelines for practical patient management.
Learning objectives:
Understand the role of glucagon and glucagon-receptor in normal physiology and disease.
Understand the rationale of a combined dual GLP-1/GCG RA and its potential benefit compared to a GLP-1RA alone and thus gain insights into th...
2025-04-041h 06
EASL Video PodcastsEASL DeepDive: Evolving insights in role and management of Alpha-1 Antitrypsin DeficiencyIn this EASL DeepDive held on 06 November 2024, Alice Turner, Pavel Strnad, and Nicola Brunetti discuss and explore the changing insights in the management of Alpha-1 Antitrypsin Deficiency.
Learning objectives:
Learn more about the role of heterozygosity of alpha-1 as a risk factor for chronic liver disease, especially in the context of other causes such as MASLD or alcohol
Get a better understanding of the extrahepatic manifestations and the need for a multi-disciplinary approach
Learn more about screening: who to screen and how
Discover the general unmet needs related to AAT, with an emphasis on awareness and...
2025-04-041h 07
EASL Video PodcastsEASL DeepDive: What is the future of PBC treatment?In this EASL DeepDive held on 25 February 2025, Ana Lleo, Adriaan van der Meer, Gideon Hirschfield, and Bettina Hansen explore the future of primary biliary cholangitis (PBC) treatment. Discover the emerging therapies, current challenges and personalised approaches that are shaping the management of PBC.
Learning objectives
Learn more about the molecular mechanisms underlying the disease and the potential targets for drug therapy
Get a good understanding of the efficacy of the current drugs and the potential added value of the upcoming second line treatments for PBC and where to position these new treatments in the treatment landscape
Learn more a...
2025-04-0459 min
EASL PodcastsEASL DeepDive: Glucagon in MASH: A next step in “metabolic” drugs tackling liver disease?In this EASL DeepDive held on 30 October 2024, Henning Grønbæk, Cyrielle Caussy, Mazen Noureddin and Frank Tacke provide an understanding of the role of glucagon and glucagon-receptors in physiology and in MASH patients. Additionally, they review key clinical trials and evaluate the integration of GLP-1 receptor agonists into current EASL-EASD-EASO clinical guidelines for practical patient management.Learning objectives:Understand the role of glucagon and glucagon-receptor in normal physiology and disease.Understand the rationale of a combined dual GLP-1/GCG RA and its potential benefit compared to a GLP-1RA alone and thus gain in...
2025-04-041h 06
EASL PodcastsEASL Studio Podcast: Rare Liver Malignancies: Small Numbers, Big QuestionsRare liver tumors like combined HCC/CCA, fibrolamellar HCC, and haemangioendothelioma pose significant diagnostic and therapeutic challenges. In this episode, we explore the latest insights, controversies, and clinical approaches outlined in the new EASL position paper. Join us to uncover how these advancements can address key hurdles in managing these rare malignancies.Read the position paper: Rare primary liver cancers: An EASL position paperModerator: Thomas BergFaculty: Ruben de Kleine and Henning WegeRelated episodesS6E4: World Cholangiocarcinoma Day: Highlighting guidelines and...
2025-03-2744 min
EASL PodcastsEASL Studio Podcast: From Evidence to Action: Reducing Alcohol-Related HarmThis episode of EASL Studio explores insights from the European Alcohol Health Alliance Symposium, hosted by the WHO Regional Office for Europe in collaboration with EASL. Topics include managing alcohol marketing strategies, addressing gaps in cancer-related labelling, and understanding the influence of social norms on adolescent alcohol consumption. Learn from successful alcohol policy implementations and discover how the WHO Playbook can empower advocates to protect children and reshape public health strategies for alcohol-related harm.Moderator: Shira Zelber-SagiFaculty: Frank Murray, Catherine Paradis (WHO Europe) and Debbie ShawcrossRelated...
2025-03-2032 min
EASL PodcastsEASL Studio Podcast: Lessons from Your PET: Understanding and Evaluating Treatment for Wilson’s DiseaseTune into this EASL Studio episode to learn about the role of PET imaging in Wilson’s disease. Discover how PET advances understanding, supports treatment decisions, and enhances patient care in managing this rare liver disorder.Moderator: Debbie ShawcrossFaculty: Aftab Ala, Zoe Mariño and Thomas SandahlThis EASL Studio is supported by Orphalan and Univar Solutions.EASL has received no input from Orphalan or Univar Solutions with regards to the content of this programme.Related episodesS4E15: Diagnostic and therapeutic challenges in...
2025-03-0638 min
EASL PodcastsEASL Studio Podcast: Liver Cancer Care in 2025: Progress, Hope, and What Lies AheadJoin this EASL Studio episode for a clinical perspective on advancing HCC care. Explore the realities of adjuvant therapies, emerging molecular targets, and strategies for curative conversion. Gain insights into practical innovations shaping the future and translating research into improved patient outcomes.Moderator: Thomas BergFaculty: Tim Greten and Anna SaborowskiThis EASL Studio is supported by Bayer.EASL has received no input from Bayer with regards to the content of this programme.Related episodesEASL Studio S5E13: Basics in decision-making for liver...
2025-02-2744 min
EASL PodcastsEASL Studio Podcast: YI choice: From Idea to Abstract to Publication: Navigating Your Research journeyWatch this EASL Studio to start navigating your research journey with essential tips on generating ideas, refining hypotheses, and crafting standout abstracts for EASL Congress. Discover how to choose the right journal, prepare a submission-ready manuscript, and boost your career visibility in hepatology.Moderator: Thomas MarjotFaculty: Marta Afonso, Emma Andersson and Paolo AngeliRelated episodesS4E20 – COST Actions: Opportunities for pan-European collaborations in liver diseasesS4E14 – EASL-EF CLIF and EU Grants: Exploring novel mechanism and treatment of chronic liver failureS4E2 YI Choice – How to build...
2025-02-2031 min
EASL PodcastsEASL Studio Podcast: JHEP Live – EASL CPGs on Hepatocellular Carcinoma: What’s New and How Will Practice Change?Discover the latest updates from the updated EASL Clinical Practice Guidelines on Hepatocellular Carcinoma (HCC). This episode explores key advancements, their impact on clinical practice, and how they will shape the future of HCC diagnosis, treatment, and management. Join our faculty as they break down the changes and provide practical insights for healthcare professionals.Moderator: Thomas BergFaculty: Peter Galle, Josep Llovet and Lorenza RimassaRelated episodesEASL Studio S6E4: World Cholangiocarcinoma Day: Highlighting Guidelines and Exploring the Horizon BeyondEASL Studio S6E9: Therapy Hierarchy in...
2025-02-1348 min
EASL PodcastsEASL Studio Podcast: 2025 Update on Steatotic Liver Disease: Rethinking Standard of CareJoin us for the season premiere of EASL Studio Season 8 as we unpack key insights from the Steatotic Liver Disease (SLD) Summit. Explore the evolving consensus on patient trajectories, advancements in ALD and MetALD treatment pathways, and the latest endpoint discussions. The episode also highlights a holistic approach to diagnosing and managing comorbidities and revisits the standard of care in light of breakthroughs in MASH treatments.Moderator: Aleksander KragFaculty: Cyrielle Caussy, Sven Francque and Brian LeeThis EASL Studio is supported by Madrigal. EASL has received no input from...
2025-02-0634 min
EASL PodcastsEASL Studio Podcast: TIPS: How far can we go?This EASL Studio episode examines the current relevance of Hepatic Encephalopathy (HE) and the roles of hepatologists and interventional radiologists in patient care. The discussion covers technical approaches, patient outcomes, and the expanding indications for TIPS.Tune in to:Learn about the critical roles of hepatologists and radiologists in managing HE.Understand technical factors, including TIPS procedures and their application in modern hepatology.Explore the use of TIPS for aging patients, those with variceal bleeding, and major surgery candidates.FacultyVirginia Hernández-Gea (Moderator)Dominique Thabut (Faculty)Dhiraj Tripathi (Faculty)Thomas Krönc...
2024-12-0536 min
EASL PodcastsEASL Studio Podcast: Alcohol, cardiometabolic risks factors, and steatotic liver disease – From stigma to breakthrough therapiesThis EASL Studio episode explores how alcohol worsens liver disease in patients with cardiometabolic risks, the stigma affecting diagnosis and care, and the latest therapeutic advances.Key topics of discussion include:Interaction between alcohol and cardiometabolic risksStigma and its impact on patient careIdentifying at-risk patients with clinical markersEmerging therapies and research opportunitiesFacultyAleksander Krag (Moderator)Fredrik Åberg (Faculty)Maru Rinella (Faculty)Maja Thiele (Faculty)This EASL Studio is supported by Boehringer Ingelheim. EASL has received no input from Boehringer Ingelheim with regards to the content of this programme.
2024-11-2135 min
EASL PodcastsEASL Studio Podcast: What’s hot and not in liver transplantation: EASL CPG 2024 updateJoin the experts as they explore the new updates to the liver transplantation clinical practice guidelines, and delve into the latest advancement and ongoing challenges faced in this field.Tune in to:Discover cutting-edge techniques like machine perfusion and extended criteria grafts.Learn about new transplant indications, including oncology and acute liver failure.Understand challenges in immunosuppression and the management of chronic rejection.FacultyAhmed Elsharkawy (Moderator)Didier Samuel (Faculty)Julie Heimbach (Faculty)Sarwa Darwish (Faculty)Related episodesEASL Studio S4E13: JHEP Live: Liver transplantation for alcohol-related...
2024-11-1444 min
EASL PodcastsEASL Studio Podcast: Why does WHO engagement with Steatotic Liver Disease matter?This episode is organised in collaboration with the Healthy Livers, Healthy Lives Coalition.FacultyJeffrey Lazarus (Moderator)Mazen Noureddin (Faculty)Shira Zelber-Sagi (Faculty)Kremlin Wickramasinghe (Faculty)The Healthy Livers, Healthy Lives Coalition’s activities are supported by Boehringer Ingelheim, Echosens, MSD, and Novo Nordisk.Our industry partners have had no input into the content of the Health Livers, Healthy Lives Coalition’s activities or this EASL Studio episode.Related episodesEASL Studio at the Congress 2024: MASLD anno 2024: A rapidly changing landscapeEASL Studio S6E7: The impact of p...
2024-10-0336 min
EASL PodcastsEASL Studio Podcast: Is it time to abandon the use of ultrasound for HCC surveillance in MASLD?This episode explores the latest developments in liver disease, with a focus on metabolic-associated steatotic liver disease (MASLD) and its impact on liver cancer, particularly hepatocellular carcinoma (HCC). The main focus is the emerging role of advanced imaging technologies. The discussion:Compares traditional ultrasound with advanced imaging techniques.Examines AI-based approaches in patient classification.The episode concludes with a forward-looking perspective on the future management of MASLD.FacultyThomas Berg (Moderator)Timm Denecke (Faculty)Juan-Manuel Pericàs (Faculty)Valérie Vilgrain (Faculty)This EASL Studio is supported by Bayer. EASL has re...
2024-09-2649 min
EASL PodcastsEASL Studio Podcast: Are we relearning how to manage renal dysfunction in cirrhosis?Renal dysfunction is a significant concern for patients with liver cirrhosis, affecting nearly 50% of those hospitalised and leading to various complications that can reduce survival rates. Recently, the diagnostic criteria for acute kidney injury (AKI) and hepatorenal syndrome (HRS) have been updated to better capture the diversity and incidence of these conditions in cirrhotic patients.This episode of EASL Studio:Explores the updated definitions and standardisation of AKI in the context of cirrhosis.Reviews recent clinical trials, including ATTIRE and CONFIRM, and their implications for patient care.Provides a critical analysis of current and emerging strategies...
2024-09-0538 min
EASL PodcastsEASL Studio Podcast: Buongiorno Milano: What not to miss during EASL CongressEASL Studio - Buongiorno Milano: What not to miss during EASL Congress.FacultyAleksander Krag (Moderator)Debbie Shawcross (Faculty)Thomas Berg (Faculty)Ahmed Elsharkawy (Faculty)All EASL Studio Podcasts are available on EASL Campus.
2024-06-1224 min
EASL PodcastsEASL Studio Podcast: Landmark studies at the EASL Congress 2024EASL Studio - Landmark studies at the EASL Congress 2024FacultyThomas Berg (Moderator)Rajiv Jalan (Faculty)Verena Keitel (Faculty)Frank Tacke (Faculty)All EASL Studio Podcasts are available on EASL Campus.
2024-06-1245 min
EASL PodcastsEASL Studio Podcast: Education at the heart of EASL’s missionEASL Studio - Education at the heart of EASL’s missionFacultySven Francque (Moderator)Krista Rombouts (Faculty)Rajeshwar Mookerjee (Faculty)Henning Grønbæk (Faculty)All EASL Studio Podcasts are available on EASL Campus.
2024-06-1224 min
Surfing the MASH TsunamiS5 - E17 - Previewing EASL Congress 2024 and its Major MASLD MomentsNext week, 7,000+ hepatology stakeholders will convene in Milano, Italy, to consume 2,000+ posters and presentations, including an extensive set of MASLD studies, at EASL Congress 2024. EASL Secretary General Aleksander Krag, Hannes Hagstrom, and Michelle Long join Jörn Schattenberg and Roger Green to preview the program.00:00:00 - Surf's Up: Season 5 Episode 17Standard lead-in, including quotes from panelists.00:02:40 - IntroductionRoger describes the structure of this episode.00:04:21 - Groundbreaker Good personal and professional news from the panelists. 00:08:04 - A 10,000m look at the EASL Congress 2024Aleksander discusses the preparation tha...
2024-05-3059 min
EASL PodcastsEASL Studio Podcast: What‘s hot in viral hepatitis in 2024?This session covers a wide range of topics relevant to the current landscape of viral hepatitis, including elimination efforts, resistance to direct-acting antivirals (DAAs), surveillance methods during and after therapy. This talk provides you with valuable insights through an up-to-date overview of the latest developments and challenges in the field.FacultyThomas Berg (Moderator)Jordan Feld (Faculty)Norah Terrault (Faculty)Heiner Wedemeyer (Faculty)This episode is scheduled in honour of the United States’ Viral Hepatitis Awareness Month.This EASL Studio is supported by GSK and Vir Biotechnology. EASL has received no in...
2024-05-3050 min
EASL PodcastsEASL Studio Podcast: YI Choice: Citizen science: Societal engagement in hepatologyThis episode aims at highlighting the importance of patient and public involvement in research. More precisely, the speakers focus on the importance of involving patients in research, practical steps to involve patients in research, and insights from EASL including engagement of patients in the EASL-Lancet Commission.FacultyMarta Alonso-Peña (Moderator)Kate Jack (Faculty)Marko Korenjak (Faculty)Thomas Marjot (Faculty)Related episodeEASL Studio from EASL Congress 2023: United we stand: Global societies collaborating to beat liver disease.All EASL Studio Podcasts are available on EASL Campus.
2024-03-2831 min
EASL PodcastsEASL Studio Podcast: Therapy hierarchy in HCC: A new kid on the blockThis episode centres around an article recently published in the Journal of Hepatology, presenting a new treatment algorithm positioned as an evolution of the BCLC system and aimed at addressing its limitations in the staging and therapy hierarchy for HCC. This discussion covers the implications of this fresh approach in the management of HCC patients, challenging the standard paradigm.FacultyBruno Sangro (Moderator)Umberto Cillo (Faculty) Helen Reeves (Faculty)María Reig (Faculty)This EASL Studio is supported by AstraZeneca. EASL has received no input from AstraZeneca with regards to the content of th...
2024-03-2140 min
EASL PodcastsEASL Studio Podcast: Is there a role for measuring blood ammonia in patients with cirrhosis?In this episode, the faculty review the evidence base for ammonia measurement in patients with cirrhosis, exploring whether hyperammonaemia is indicative of a poor prognosis and if erroneous measurements correlate with the efficacy of ammonia-lowering therapies. The debate also extends to the use of ammonia as a potential endpoint in randomised controlled trials for hepatic encephalopathy drugs.FacultyDebbie Shawcross (Moderator)Rajiv Jalan (Faculty)Sara Montagnese (Faculty)Elliot Tapper (Faculty)This EASL Studio episode is organised in collaboration with the International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN).Related...
2024-03-1433 min
EASL PodcastsEASL Studio Podcast: The impact of policy measure in preventing liver diseases: The Hepahealth II studyThis episode treats of the Hepahealth II study, which aimed at estimating the impact of policy interventions targeting alcohol and obesity on the incidence of chronic liver disease and primary liver cancer in three European countries. Join our experts in their discussion of this study and of its conclusions.FacultyPatrizia Burra (Moderator)Maria Buti (Faculty)Peter Jepsen (Faculty)Shira Zelber-Sagi (Faculty)Related episodesEASL Studio S6E1: Do we solve MASLD by treating obesity?EASL Studio from EASL Congress 2023: The battle to reduce alcohol harms… EASL’s new policyEASL Stud...
2024-03-0731 min
EASL PodcastsEASL Studio Podcast: Alpha-1-antitrypsin deficiency (AATD): A poster child for genetic therapyOn the eve of the rare disease day, our guests discuss the compelling reasons why AATD stands out as the prime candidate for gene therapy. This talk addresses the pertinence of the subject in the current research landscape and highlight ongoing global trials opening the door for new opportunities in this field.FacultyAleksander Krag (Moderator)Aftab Ala (Faculty)Pavel Strnad (Faculty)Alice Turner (Faculty)Related episodesEASL Studio from EASL Congress 2023: Clinical trials in rare diseases – opportunities and challengesEASL Studio from ILC 2022: Rare Liver Diseases – A growing landscape of oppo...
2024-02-2935 min
EASL PodcastsEASL Studio Podcast: JHEP Live: Should the compensated advanced chronic liver disease (cACLD) concept replace cirrhosis?The definition of cACLD is now strongly linked to care and research outcomes such as non invasive diagnosis, reversibility and prevention of decompensation. Thus, what space is left for the use of the old term cirrhosis in clinical practice and research?FacultyPaolo Angeli (Moderator)Guadalupe Garcia-Tsao (Faculty)Valérie Paradis (Faculty)Thomas Reiberger (Faculty)Related episodesEASL Studio S5E5: JHEP Live: the new nomenclature for SLD: a multidisciplinary evaluation and approachEASL Studio from EASL Congress 2023: Steatotic liver disease global consensus to change nomenclatureEASL Studio S4E4: JHEP Live: I...
2024-02-2231 min
EASL PodcastsEASL Studio Podcast: World Cholangiocarcinoma Day: Highlighting guidelines and exploring the horizon beyondIn this exclusive session, Thomas Berg and his panelists examine the intricate world of intrahepatic Cholangiocarcinoma (iCCA), following the publication of the EASL clinical practice guidelines on iCCA in 2023. This discussion aim at raising awareness and promoting a deeper understanding of this complex condition, while touching upon the topic of targeted therapies, highlighting the advancements and challenges that lie ahead.FacultyThomas Berg (Moderator)Katie Kelley (Faculty)Daniela Sia (Faculty)Juan Valle (Faculty)This episode is scheduled in honour of the World CCA Day (15 February) and the US CCA Awareness Month.
2024-02-1545 min
EASL PodcastsEASL Studio Podcast: Do we solve MASLD by treating obesity?Our speakers explore the latest insights into the adipose tissue-liver axis, focusing on weight-reducing drugs’ current status and the crucial question of who should prescribe them and how efficacy should be monitored. They debate the implications of these drugs, their expected outcomes, and their integration into the toolkit of hepatologists.Don’t miss this opportunity to grasp the evolving dynamics between obesity treatment and MASLD management!FacultySven Francque (Moderator)Willem Pieter Brouwer (Faculty)Cyrielle Caussy (Faculty)Dimitris Papamargaritis (Faculty)This episode is scheduled following the United Kingdom’s National Obesity Awaren...
2024-01-2533 min
EASL PodcastsEASL Studio Podcast: Hepatic encephalopathy: Underdiagnosed and underestimatedHepatic encephalopathy (HE) is a common reversible complication of advanced liver disease characterised by a spectrum of neuropsychiatric abnormalities. Due to its insidious onset, most patients only seek treatment once complications develop, resulting in it being an underdiagnosed and underestimated condition.This EASL Studio episode, organised in collaboration with the International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN), explores the patient journey and treatment options.FacultyDebbie Shawcross (Moderator)Christian Labenz (Faculty)Steve Rodrigues (Faculty)Dominique Thabut (Faculty)This EASL Studio is supported by Norgine. EASL has received no input...
2023-12-1435 min
EASL PodcastsEASL Studio Podcast: Basics in decision-making for liver cancer treatmentWith cases of hepatocellular carcinoma on the rise and representing the end stage of many chronic liver diseases, the treatment of liver cancer has become one of the most dynamic areas in hepatology. The focus of this episode is on answering practical clinical questions, examining trial data, and sharing clinical insights that may be useful for decision-making in daily clinical practice.FacultyTom Lüdde (Moderator)Christoph Roderburg (Faculty)Anna Saborowski (Faculty)Arndt Vogel (Faculty)This EASL Studio is supported by AstraZeneca and Eisai. EASL has received no input from AstraZeneca or Eisai w...
2023-12-0733 min
EASL PodcastsEASL Studio Podcast: PSC and AIH overlap syndrome: does it actually exist?This episode explores key aspects of intriguing intersection of autoimmune liver diseases, such as their distinctive presentations in childhood and adulthood and the influence of inflammatory bowel disease on liver disease phenotypes. The speakers also examines the benefits and risks associated with immunosuppressive treatments in managing these complex conditions.FacultyPalak Trivedi (Moderator)Amanda Ricciuto (Faculty)Marianne Samyn (Faculty)Christoph Schramm (Faculty)This EASL Studio is supported by Chemomab Therapeutics. EASL has received no input from Chemomab Therapeutics with regards to the content of this programme.Related episodes...
2023-11-3029 min
EASL PodcastsEASL Studio Podcast: The window hypothesis again, or just a closed window?The treatment of liver cirrhosis – currently based on symptomatic management of complications – has barely changed in last 20 years. In this episode, the experts discuss the use of statins, for which there is growing body of evidence of their beneficial effects in patients suffering with cirrhosis.FacultyThomas Reiberger (Moderator)Juan Gonzalez-Abraldes (Faculty)Elisa Pose (Faculty)Jonel Trebicka (Faculty)This EASL Studio is supported by Boehringer Ingelheim. EASL has received no input from Boehringer Ingelheim with regards to the content of this programme.Related episodesEASL Studio from EASL Cong...
2023-11-2332 min
EASL PodcastsEASL Studio Podcast: Why should diabetologists care about the liver?In this episode, participants tackle the relationship between metabolic dysfunction-associated steatotic liver diseases (MASLD) and type 2 diabetes (T2D), exploring their prevalence and the potential for more aggressive outcomes. Experts weigh in on the pressing questions of whether non-invasive test thresholds should be adapted for MASLD patients with T2D and which drugs should take precedence as first-line treatments for high-risk MASLD cases.FacultyZobair Younossi (Moderator)Laurent Castera (Faculty)Camilla Dalby Hansen (Faculty)Amalia Gastaldelli (Faculty)This episode is scheduled according to the international calendar for the World Diabetes Day (14 November).
2023-11-1636 min
EASL PodcastsEASL Studio Podcast: Alcohol and the new nomenclature – A game-changer?In honour of the Awareness Week on Alcohol related harm (21 November – 1 December), this episode discussed how the new nomenclature will affect healthcare pathways for those suffering with Alcohol-related liver diseases.Faculty Aleksander Krag (Moderator)Juan Pablo Arab (Faculty)Alexandre Louvet (Faculty)Maru Rinella (Faculty)Related episodes:EASL Studio from EASL Congress 2023: Steatotic liver disease global consensus to change nomenclatureEASL Studio S4E8: The central role of alcohol and food policies on liver healthEASL Studio S3E5: JHEP Live: Stigma and alcoholAll EASL Studio Podcasts are available on EAS...
2023-11-0937 min
EASL PodcastsEASL Studio Podcast: Highlights from the EASL SLD Summit 2023This EASL Studio episode covers the highlights of the SLD Summit 2023, including:Physiopathological mechanismProblems encountered in the cirrhotic stage in SLDNovelties about liver biopsiesFacultySven Francque (Moderator)Quentin Anstee (Faculty)Frank Tacke (Faculty)Maja Thiele (Faculty)Related episodesEASL Studio S5E2: Are 30% of the global population sick? A critical view on Steatotic Liver Disease and care pathwaysEASL Studio Live from EASL Congress 2023: Steatotic liver disease global consensus to change nomenclatureEASL Studio S4E23: The conundrum of NASH: The growing global disease burden with low disease awarenessEASL Studio S4E22: JHEP...
2023-09-2733 min
EASL PodcastsEASL Studio Podcast: United we stand: Global societies collaborating to beat liver diseaseThis EASL Studio Midday Talks was live broadcast during the EASL Congress 2023 and is presenting the work of international liver societies to beat liver diseases.FacultyThomas Berg, EASL (Moderator)Marcelo Silva, ALEH (Faculty)Norah Terrault, AASLD (Faculty)Manal El-Sayed, SOLDA (Faculty)Shiina Shuichiro, APASL (Faculty)All EASL Studio Podcasts are available on EASL Campus.
2023-08-1836 min
EASL PodcastsEASL Studio Podcast: Practice changing highlights from EASL Congress 2023This EASL Studio Midday Talks was live broadcast during the EASL Congress 2023 and is covering practice changing following data presented during the congress.FacultyVirginia Hernández-Gea (Moderator)Ahmed Elsharkawy (Moderator)Maru Rinella (Faculty)Maria Reig (Faculty)Nancy Reau (Faculty)Verena Keitel (Faculty)All EASL Studio Podcasts are available on EASL Campus.
2023-08-1729 min
EASL PodcastsEASL Studio Podcast: EASL Congress 2023: Back to the futureThis EASL Studio Closing was live broadcast during the EASL Congress 2023 and discusses the future of hepatology.FacultyThomas Berg (Moderator)Aleksander Krag (Moderator)Tobias Böttler (Faculty)Debbie Shawcross (Faculty)All EASL Studio Podcasts are available on EASL Campus.
2023-08-1728 min
EASL PodcastsEASL Studio Podcast: Highlights of liver cancer research at EASL Congress 2023This EASL Studio Good Morning Vienna was live broadcast during the EASL Congress 2023 and is presenting the highlights of liver cancer research at the congress.FacultyJean-Charles Nault (Moderator)Josep Llovet (Moderator)Jessica Zucman-Rossi (Faculty)Bruno Sangro (Faculty)Matthias Pinter (Faculty)All EASL Studio Podcasts are available on EASL Campus.
2023-08-1729 min
EASL PodcastsEASL Studio Podcast: The battle to reduce alcohol harms… EASL’s new policyThis EASL Studio Midday Talks was live broadcast during the EASL Congress 2023 and discusses the newly released EASL policy statement on alcohol harm and related liver diseases. The document aims to highlight the extensive harm resulting from alcohol consumption and shine a light on the effective, yet underused, harm reduction policies available to European countries.FacultyFrank Murray Ireland (Moderator)Maria Buti (Moderator)Thomas Babor (Faculty)All EASL Studio Podcasts are available on EASL Campus.
2023-08-1731 min
EASL PodcastsEASL Studio Podcast: Steatotic liver disease global consensus to change nomenclatureThis EASL Studio Midday Talks was live broadcast during the EASL Congress 2023 and discusses the nomenclature change for steatotic liver disease.FacultyAleksander Krag, EASL (Moderator)Philip Newsome, EASL (Faculty)Maru Rinella, AASLD (Faculty)Graciela Castro-Narro, ALEH (Faculty)Mohamed El-Kassas, SOLDA (Faculty)Robert Mitchell-Thain, LPI (Faculty)Lorraine Stiehl, ALF (Faculty)All EASL Studio Podcasts are available on EASL Campus.
2023-08-1737 minSurfing the MASH TsunamiS4-E21.2 - Previewing EASL Congress 2023: Highlighting Exciting ElementsSurfing NASH offers an exciting preview of EASL Congress 2023 with new guest and EASL Vice-Secretary, Aleksander Krag, alongside EASL Educational Councillor, Sven Francque, and Surfers Jörn Schattenberg, Louise Campbell and Roger Green. The world’s largest liver meeting takes place 21-24 June in Vienna with an international faculty of experts from over 200 institutions. The diverse program will feature 2500 abstracts and be a uniquely momentous occasion for developing multidisciplinary approaches aimed at putting a major dent in Fatty Liver disease.This conversation begins with Jörn describing his anticipations for the meeting where he will be Chair of t...
2023-05-2811 minSurfing the MASH TsunamiS4-E21.1 Meeting Aleksander Krag and Setting the Stage for EASL Congress 2023Surfing NASH offers an exciting preview of EASL Congress 2023 with new guest and EASL Vice-Secretary, Aleksander Krag, alongside EASL Educational Councillor, Sven Francque, and Surfers Jörn Schattenberg, Louise Campbell and Roger Green. The world’s largest liver meeting takes place 21-24 June in Vienna with an international faculty of experts from over 200 institutions. The diverse program will feature 2500 abstracts and be a uniquely momentous occasion for developing multidisciplinary approaches aimed at putting a major dent in Fatty Liver disease. In this conversation, the audience is introduced to Aleksander and his work in Fatty Liver disease. He des...
2023-05-2813 min
EASL PodcastsEASL Studio Podcast: Promoting Liver Health: An urgent call for action at WHOOn 22 May 2023, policymakers, thought leaders, Permanent Mission Representatives to the UN, WHO staff, and people affected by liver disease will gather at the EASL Office in Geneva for the invitation-only event on the side-lines of the 76th World Health Assembly*: “Together for Better Liver Health: Mobilising Action for Fatty Liver Disease”. The aim of the event is to raise awareness on the need for action, and to call for a coordinated response to combat the global public health threat represented by fatty liver disease.Fatty liver disease is the most prevalent liver disease in history, affecting over one...
2023-05-2429 minSurfing the MASH TsunamiS4-E21 - Surfing NASH Previews EASL Congress 2023Surfing NASH offers an exciting preview of EASL Congress 2023 with new guest and EASL Vice-Secretary, Aleksander Krag, alongside EASL Educational Councillor, Sven Francque, and Surfers Jörn Schattenberg, Louise Campbell and Roger Green. The world’s largest liver meeting takes place 21-24 June in Vienna with an international faculty of experts from over 200 institutions. The diverse program will feature 2500 abstracts and be a uniquely momentous occasion for developing multidisciplinary approaches aimed at putting a major dent in Fatty Liver disease. In this lively session, the group covers the following topics and more:
2023-05-1851 min
EASL PodcastsEASL Studio Podcast: A new strategy for liver cancer screening: EASL Policy Statement on risk-based surveillanceThe EASL Policy Statement on liver cancer screening has recently been updated.In addition to addressing the updates, this episode of EASL Studio will discuss how risk-based surveillance of hepatocellular carcinoma (HCC) in patients suffering from cirrhosis is a cost effective strategy to increase benefits, reduce the harm of HCC surveillance.FacultyProf. Thomas Berg (Moderator)Mr. Pietro Fiocchi (Faculty)Prof. Peter Jepsen (Faculty)Mrs. José Willemse (Patient Perspective) All EASL Studio Podcasts are available on EASL Campus.
2023-04-1942 min
EASL PodcastsEASL Studio Podcast: EASL-EF CLIF and EU Grants: Exploring novel mechanism and treatment of chronic liver failureThrough widespread multidisciplinary collaboration, consortia and EU grants provide unique opportunities to address critical questions.What opportunities exist for early career scientist?Which elements are essential for success?How have these partnerships contributed to advancements in the field?Watch this episode of EASL Studio to find out.FacultyProf. Thomas Berg (Moderator)Prof. Rajiv Jalan (Moderator)Prof. Minneke Coenraad (Faculty)Dr Cornelius Engelmann (Faculty)Prof. Pierre-Emmanuel Rautou (Faculty)Related episodeS4E2 YI Choice: How to build consortia and registriesAll EASL Studio Podcasts are available on...
2023-04-1337 min
The Profluence Pod 🌐#14: Matt Beyer - CEO, Co-Founder East Asia Super League (EASL) | Building a sports league from scratch | Future of basketball | Importance of media + fan engagement | Asian sports ecosystemAfter several years of building a sports agency in China, Matt Beyer decided to start the East Asia Super League (EASL). It is the top basketball league in Asia, similar to the Champions League in European soccer.
The EASL combines the best Asian clubs and leagues with the goal of becoming one of the world’s top three professional basketball leagues by 2025.
Prior to building the EASL, Beyer spent time working for the NBA, as an agent, and in Chinese public relations. He speaks fluent Mandarin Chinese.
Chapters:
(01:30) Backstory of the EA...
2023-02-0539 min
EASL PodcastsEASL Studio Podcast: A 360 approach to beat alcohol-related liver diseaseAlcohol is the main cause of advanced liver disease and a major cause of hospitalisation and disability across the globe, including Europe. In this EASL Studio you will hear the patient perspective from an individual who has overcome this disease and listen to the faculty discuss the measures that can help prevent it.FacultyProf. Ramon Bataller (Moderator)Prof. Giovanni Addolorato (Faculty)Prof. Peter Jepsen (Faculty)Prof. Debbie Shawcross (Faculty)Mrs Kristen Radage (Faculty)Mr. Steven Rodrigues (Patient Perspective)Related episodesS3E5: JHEP Live: Stigma and alcoholS3E4: Special Edition: Highlights...
2023-01-2644 min
EASL PodcastsEASL Studio Podcast: Special Edition: Highlights of EASL NAFLD Summit 2022This episode of EASL Studio discusses the latest data in the treatment of NAFLD presented at the EASL NAFLD Summit 2022.FacultyProf. Amalia Gastaldelli (Faculty)Prof. Frank Tacke (Faculty)Prof. Emmanuel Tsochatzis (Faculty)All EASL Studio Podcasts are available on EASL Campus.
2022-09-2932 min
EASL PodcastsEASL Studio Podcast: EASL Haemochromatosis Guidelines 2022In honour of World Haemochromatosis week (1-7 June 2022) the newly updated EASL Clinical Practice Guidelines on Haemochromatosis will be discussed in this episode of EASL Studio.Read moreAll EASL Studio Podcasts are available on EASL Campus.
2022-06-1643 min
EASL PodcastsEASL Studio Podcast - YI Choice: Propelling liver cell biology into the third dimensionReduce, Refine, Replace. Developed over 50 years ago, the 3Rs provide a framework that urges researchers to think carefully about methods used to investigate scientific questions. In this episode of EASL Studio, we took a closer look at the third R, Replace. With the World Day for Laboratory Animals fast approaching, we discussed how to propel liver cell biology into the third dimension.What are the advantages of 3D cultures?Can liver cell types be studied in representative manner using 3D cultures?More importantly, which part of animal research can be replaced by 3D cell culture experiments?This...
2022-04-2138 min
EASL PodcastsEASL Studio Podcast: Should anticoagulants be given to patients with cirrhosis to improve outcome?Discover this EASL Studio Podcast highlighting the recently published EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis. Join the faculty as they discuss:What effects do anticoagulants have on survival and liver related events in cirrhosis?What are the mechanisms of action?What type of anticoagulants should be used in patients with cirrhosis?Read moreAll EASL Studio Podcasts are available on EASL Campus.
2022-04-0530 min